OakChart

Gilead Sciences Inc

GILDHealthcare·Drug Manufacturers - General·USA·Mega·NASD·Nov 11 • 3:59 PM ET

169.73-1.14 (-0.67%)
2026-11-12 07:34 CET
Market cap
210,522.91 USD m
Revenue, TTM
31,064.00 USD m
Net income, TTM
-3,863.00 USD m
Free cash flow, TTM
13,780.00 USD m
EPS diluted, TTM
-3.15
P/E
-
Compare

Price

GILD against its 20, 50 and 200-day averages
2050200beatmiss
Patternshover a marker to name it
Sales mean, own scale
Sales 8,298Price8,1338,177120.00140.00160.009.9M19.9MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26GILDclose 169.7320-day 162.9950-day 154.40200-day 141.44169.7352w high

3.9% under the 52-week high of 176.58 on 5 Nov 2026. 52-week low 116.88 on 5 Jan 2026. Last 15 sessions, 15.4% high to low

Volume 0.81× normal · the line is the 50-bar volume average

Profile

GILD
52-week range, 89% of the way up
116.88176.58

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

IndexNDX, S&P 500, RUI
Employees17000
IPOJan 22, 1992
Beta0.37
ATR, 14d4.80
Rel volume0.81
Short float1.72%
Insider own0.16%
Inst own91.94%

Snapshot

6 groups

Valuation

IndexNDX, S&P 500, RUI
Market Cap210.52B
Enterprise Value228.72B
Income-3.86B
Sales31.06B
Book/sh10.51
Cash/sh6.41
Dividend Est.3.30 (1.94%)
Dividend TTM3.25 (1.91%)
Dividend Ex-DateDec 15, 2026
Dividend Gr. 3/5Y2.67% 3.04%
Payout46.60%
Employees17000
IPOJan 22, 1992

Ratios

P/E-
Forward P/E16.77
PEG1.73
P/S6.78
P/B16.16
P/C26.47
P/FCF15.28
EV/EBITDA15.54
EV/Sales7.36
Quick Ratio1.22
Current Ratio1.38
Debt/Eq2.01
LT Debt/Eq1.83
Option/ShortYes / Yes

Earnings

EPS (ttm)-3.15
EPS next Y10.12
EPS next Q1.29
EPS this Y-110.68%
EPS next Y1262.38%
EPS next 5Y9.71%
EPS past 3/5Y23.06% 133.64%
Sales past 3/5Y2.83% 3.63%
EPS Y/Y TTM-147.65%
Sales Y/Y TTM6.92%
EPS Q/Q-20.22%
Sales Q/Q6.68%
EarningsOct 29 AMC
EPS/Sales Surpr.16.37% 6.34%

Ownership

Insider Own0.16%
Insider Trans-14.28%
Inst Own91.94%
Inst Trans0.46%
ROA-7.03%
ROE-22.34%
ROIC-10.48%
Gross Margin80.00%
Oper. Margin38.39%
Profit Margin-12.44%
SMA204.13%
SMA509.93%
SMA20020.00%
Trades-

Technical

Shs Outstand1.24B
Shs Float1.24B
Short Float1.72%
Short Ratio3.55
Short Interest21.27M
52W High176.58 -3.88%
52W Low116.88 45.22%
Volatility2.92% 2.79%
ATR (14)4.80
RSI (14)62.20
Beta0.37
Rel Volume0.81
Avg Volume6.00M
Volume4,883,539

Performance

Perf Week-2.72%
Perf Month14.74%
Perf Quarter22.87%
Perf Half Y27.57%
Perf YTD38.28%
Perf Year38.49%
Perf 3Y123.56%
Perf 5Y151.71%
Perf 10Y122.10%
Recom1.63
Target Price175.12
Prev Close170.87
Price169.73
Change %-0.67%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Jul 21, 2026DowngradeLLeerink PartnersOutperform → Market Perform$127-25.2%
Jul 06, 2026UpgradeHHSBC SecuritiesHold → Buy$155-8.7%
May 20, 2026UpgradeMMaxim GroupHold → Buy$165-2.8%
Mar 10, 2026InitiatedJJefferiesBuy$180+6.1%
Feb 20, 2026InitiatedBBarclaysEqual Weight$155-8.7%
Feb 11, 2026ReiteratedNNeedhamBuy$140 → $170+0.2%
Jan 07, 2026ResumedUUBSBuy$145-14.6%
Nov 24, 2025ResumedTTruistBuy$140-17.5%
Nov 13, 2025InitiatedBScotiabankSector Outperform$140-17.5%
Aug 19, 2025UpgradeDDaiwa SecuritiesNeutral → Outperform$128-24.6%

Peers

Mkt cap
TickerCompanyMkt cap
GSKGSK Plc ADR101.43B
MRKMerck & Co Inc362.83B
BMYBristol-Myers Squibb Co128.59B
AMGNAMGEN Inc253.21B
ABBVAbbvie Inc521.41B
AZNAstrazeneca plc287.66B
LLYLilly(Eli) & Co1352.12B
REGNRegeneron Pharmaceuticals Inc99.23B
VRTXVertex Pharmaceuticals Inc138.69B
BIIBBiogen Inc37.46B

Insider trading

latest 14 of 100
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Cain Wettan Keeley MEVP Gen Counsel, Legal & CompNov 06 '26Sale164.113,399557,8105,360Nov 09 07:20 PM
O'Day Daniel PatrickChairman & CEONov 04 '26Option Exercise72.34102,6197,423,458654,302Nov 06 05:15 PM
O'Day Daniel PatrickChairman & CEONov 05 '26Option Exercise72.349,810709,655561,493Nov 06 05:15 PM
O'Day Daniel PatrickChairman & CEONov 04 '26Sale175.16102,61917,975,021551,683Nov 06 05:15 PM
O'Day Daniel PatrickChairman & CEONov 05 '26Sale175.179,8101,718,418551,683Nov 06 05:15 PM
KEELEY M CAIN WETTANOfficerNov 06 '26Proposed Sale167.573,399569,570Nov 06 04:32 PM
DANIEL O'DAYDirectorNov 04 '26Proposed Sale167.47112,42918,828,485Nov 04 04:30 PM
O'Day Daniel PatrickChairman & CEOOct 30 '26Option Exercise72.3415,8811,148,832582,564Nov 02 07:14 PM
O'Day Daniel PatrickChairman & CEOOct 30 '26Sale175.2515,8812,783,075566,683Nov 02 07:14 PM
O'Day Daniel PatrickChairman & CEONov 02 '26Sale169.7415,0002,546,102551,683Nov 02 07:14 PM
DANIEL O'DAYDirectorOct 30 '26Proposed Sale165.6145,8817,598,352Oct 30 04:28 PM
Dickinson Andrew DChief Financial OfficerOct 15 '26Sale156.223,000468,660161,096Oct 16 04:17 PM
Mercier JohannaChief Comm & Corp Aff OfficerOct 15 '26Sale156.223,000468,660113,684Oct 16 04:12 PM
JOHANNA MERCIEROfficerOct 15 '26Proposed Sale156.223,000468,660Oct 15 04:22 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VOOVanguard S&P 500 ETFAUM: 1054.75B
QQQInvesco QQQ Trust Series 1AUM: 463.98B
IVViShares Core S&P 500 ETFAUM: 871.38B
SPYSPDR S&P 500 ETF TrustAUM: 793.23B
VTVVanguard Morningstar Value ETFAUM: 196.23B
XLVState Street Health Care Select Sector SPDR ETFAUM: 50.35B
VIGVanguard Dividend Appreciation FTFAUM: 117.07B
QQQMInvesco NASDAQ 100 ETFAUM: 106.59B
IBBiShares Biotechnology ETFAUM: 11.36B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-10-292.5502.1911.9408,3007,80522
2026Q22026-08-04-6.750-7.247-8.4447,8037,39920
2026Q12026-05-072.0301.9101.6126,9606,91325
2025Q42026-02-101.8601.8101.7427,9257,69022
2025Q32025-10-302.4702.1322.4347,7697,44520
2025Q22025-08-072.0101.9601.5627,0826,98219
2025Q12025-04-241.8101.7801.0456,6676,81117
2024Q42025-02-111.9001.7381.4167,5697,15223
2024Q32024-11-062.0201.5301.0057,5457,01622
2024Q22024-08-082.0101.6071.2906,9546,70320
2024Q12024-04-25-1.320-1.493-3.3446,6866,35716
2023Q42024-02-061.7201.7581.1387,1157,10124
2023Q32023-11-072.2901.9161.7347,0516,81221
2023Q22023-08-031.3401.6430.8316,5996,45423
2023Q12023-04-271.3701.5230.8016,3526,33220
2022Q42023-02-021.6701.5181.2987,3896,63522

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY6.6307.0064.21822,44922,272
2020FY7.0906.9480.09724,68924,372
2021FY7.2808.2054.93327,30526,669
2022FY7.2607.1033.63927,28126,528
2023FY6.7206.7554.50327,11627,099
2024FY4.6204.4100.38328,75428,320
2025FY8.1508.1136.78029,44329,229
2026FY--0.871--31,323
2027FY-10.122--33,534
2028FY-10.761--34,708
2029FY-12.207--37,307
2030FY-13.376--39,580

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-11191228,2988,0788,532
2026Q4S2026-11-05191238,2988,0788,532
2026Q4S2026-11-04191238,3018,0788,532
2026Q4S2026-11-03191138,2838,0348,532
2026Q4S2026-10-30191138,2838,0348,532
2026Q4S2026-10-2918328,1758,0078,842
2026Q4S2026-10-2618328,1758,0078,842
2026Q4S2026-10-2018318,1928,0078,842
2026Q4S2026-10-1918218,1777,8828,842
2026Q4S2026-10-16184128,1777,8828,842
2026Q4S2026-10-15183128,1337,8828,565
2026Q4S2026-10-13183128,1337,8828,565
2026Q4S2026-10-12183128,1357,8828,565
2026Q4S2026-10-09183128,1377,8828,565

Estimate history

EPS, annual3.5094.1714.2180.0974.9333.6394.5030.3836.781-3.1486
Period201720182019202020212022202320242025TTM
EPS, quarterly1.0051.4161.0451.5622.4341.7421.612-8.4441.942
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual26135222142232224642273722708527058287272944831064
Period201720182019202020212022202320242025TTM
Sales, quarterly753175616646706377847955698478218304
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual1308128212661254125412471246124612411241
Period201720182019202020212022202320242025MRQ
Shares, quarterly124612461245124212421241124212411241
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue31,064.0029,448.0028,727.0027,058.0027,085.0027,372.0024,642.0022,322.0022,214.00
Cost of Goods Sold Incl. D&A6,213.006,230.006,251.006,019.005,657.006,601.004,509.004,675.004,853.00
Gross Profit24,851.0023,218.0022,476.0021,039.0021,428.0020,771.0020,133.0017,647.0017,361.00
Selling, General and Administrative Excl. Other12,926.0011,396.0011,816.0011,295.0010,671.0010,570.009,689.0012,687.008,254.00
Research and Development6,209.005,688.005,816.005,758.004,998.005,363.004,857.008,306.004,198.00
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income11,925.0011,822.0010,660.009,744.0010,757.0010,201.0010,444.004,960.009,107.00
Interest Expense1,011.001,024.00977.00944.00935.001,001.00984.00995.001,077.00
Unusual Expense13,715.001,411.009,264.002,307.004,213.001,522.002,941.00-422.00707.00
Net Income Before Taxes-2,533.009,796.00690.006,859.005,814.008,278.001,669.005,160.007,799.00
Income Taxes1,330.001,286.00210.001,246.001,248.002,077.001,580.00-204.002,339.00
Consolidated Net Income-3,863.008,510.00480.005,613.004,566.006,201.0089.005,364.005,460.00
Net Income From Continuing Operations-3,863.008,510.00480.005,665.004,592.006,225.00123.005,386.005,455.00
Net Income-3,863.008,510.00480.005,665.004,592.006,225.00123.005,386.005,455.00
EPS (Recurring)4.597.575.555.795.985.781.733.994.55
EPS (Basic, Before Extraordinaries)-3.106.840.384.543.664.960.104.244.20
EPS (Diluted)-3.156.780.384.503.644.930.104.224.17
EBITDA14,718.0014,582.0013,427.0012,437.0012,860.0012,251.0011,924.006,364.0010,536.00
Non-Operating Income (Expense)268.00409.00271.00366.00205.00600.00-4,850.00773.00476.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense652.64640.00777.00630.00553.00535.00854.00638.00681.00
Price To Earnings Ratio--1,041.3817.3732.4614.71745.9715.4415.01
Price To Sales Ratio6.005.234.043.774.003.352.993.723.68
Gross Margin80.0078.8478.2477.7679.1175.8881.7079.0678.15
Operating Margin38.3940.1537.1136.0139.7237.2742.3822.2241.00
Net Margin-12.4428.901.6720.9416.9522.740.5024.1324.56
Shares Outstanding1,241.001,241.001,246.001,246.001,247.001,254.001,254.001,266.001,282.00
Market Capitalization210,522.91210,522.91115,117.96100,941.70107,676.5091,080.5373,030.6682,209.4580,915.93

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue8,304.007,821.006,984.007,955.007,784.007,063.006,646.007,561.00
Cost of Goods Sold Incl. D&A1,570.001,579.001,445.001,619.001,569.001,501.001,540.001,581.00
Gross Profit6,734.006,242.005,539.006,336.006,215.005,562.005,106.005,980.00
Selling, General and Administrative Excl. Other3,208.003,596.002,780.003,342.002,686.002,808.002,561.003,471.00
Research and Development1,600.001,690.001,354.001,565.001,334.001,450.001,339.001,611.00
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income3,526.002,646.002,759.002,994.003,529.002,754.002,545.002,509.00
Interest Expense269.00247.00240.00255.00256.00254.00260.00249.00
Unusual Expense240.0012,681.005.00789.00-317.00179.00760.00200.00
Net Income Before Taxes3,063.00-10,254.002,580.002,078.003,641.002,429.001,649.002,168.00
Income Taxes634.00242.00559.00-105.00589.00468.00334.00385.00
Consolidated Net Income2,429.00-10,496.002,021.002,183.003,052.001,960.001,315.001,783.00
Net Income From Continuing Operations2,429.00-10,496.002,021.002,183.003,052.001,960.001,315.001,783.00
Net Income2,429.00-10,496.002,021.002,183.003,052.001,960.001,315.001,783.00
EPS (Recurring)2.08-1.301.612.182.261.661.471.53
EPS (Basic, Before Extraordinaries)1.96-8.441.631.762.461.571.061.43
EPS (Diluted)1.94-8.441.611.742.431.561.041.42
EBITDA4,266.003,344.003,448.003,660.004,215.003,445.003,241.003,202.00
Non-Operating Income (Expense)46.0028.0066.00128.0050.00108.00124.00109.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense184.86183.28172.22112.28182.49178.54166.69129.56
Price To Earnings Ratio-17.1920.5519.0122.0823.31305.231,041.38
Price To Sales Ratio6.005.145.875.224.794.834.924.05
Gross Margin81.0979.8179.3179.6579.8478.7576.8379.09
Operating Margin42.4633.8339.5037.6445.3438.9938.2933.18
Net Margin29.25-134.2028.9427.4439.2127.7519.7923.58
Shares Outstanding1,241.001,241.001,242.001,241.001,242.001,242.001,245.001,246.00
Market Capitalization210,522.91156,859.95173,016.71152,281.06137,729.91137,914.52139,541.47115,117.96

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments9,613.0011,568.008,350.006,858.007,405.008,261.0024,671.0030,952.0026,145.00
Short Term Receivables4,913.004,420.004,660.004,777.004,493.004,901.003,582.003,327.003,851.00
Inventories1,774.001,710.001,787.001,507.001,618.001,683.00922.00814.00801.00
Other Current Assets2,042.001,475.001,288.001,301.001,256.001,151.001,121.00743.001,026.00
Total Current Assets18,342.0019,173.0016,085.0014,443.0014,772.0015,996.0030,296.0035,836.0031,823.00
Net Property, Plant & Equipment6,138.005,929.005,898.005,980.005,663.005,613.005,170.004,006.003,295.00
Total Investments and Advances3,369.00713.002,159.002,612.002,511.002,258.001,662.001,570.0011,184.00
Intangible Assets25,292.0028,262.0034,768.0037,208.0041,787.0041,234.0017,903.0019,855.0021,259.00
Deferred Tax Assets1,964.00-------27.00
Other Assets3,918.004,918.003,215.002,928.003,219.003,306.006,596.002,408.002,695.00
Total Assets59,023.0058,995.0062,125.0063,171.0067,952.0068,407.0061,627.0063,675.0070,283.00
Short Term Debt Incl. Current Port. of LT Debt2,909.001,928.001,923.002,273.001,617.002,864.002,598.002,748.002,747.00
Accounts Payable715.00833.00550.00905.00705.00844.00713.00790.00814.00
Income Tax Payable92.001,646.001,208.00959.00539.00598.00287.00190.00713.00
Other Current Liabilities8,097.007,597.007,599.007,100.008,749.007,091.006,161.006,877.007,361.00
Total Current Liabilities11,813.0012,004.0011,280.0011,237.0011,610.0011,397.009,759.0010,605.0011,635.00
Long Term Debt22,632.0025,394.0023,735.0022,957.0025,668.0029,253.0022,720.0024,574.0030,795.00
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities402.00724.001,588.002,673.004,356.00----
Other Liabilities1,557.001,627.002,773.005,095.005,254.009,536.006,498.006,962.007,352.00
Total Liabilities36,404.0039,749.0039,376.0041,962.0046,888.0050,186.0038,977.0042,141.0049,782.00
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity22,703.0019,330.0022,833.0021,240.0021,069.0018,202.0022,525.0021,387.0020,442.00
Total Shareholders Equity22,703.0019,330.0022,833.0021,240.0021,069.0018,202.0022,525.0021,387.0020,442.00
Accumulated Minority Interest-84.00-84.00-84.00-31.00-5.0019.00125.00147.0059.00
Total Equity22,619.0019,246.0022,749.0021,209.0021,064.0018,221.0022,650.0021,534.0020,501.00
Total Liabilities & Stockholders Equity59,023.0058,995.0062,125.0063,171.0067,952.0068,407.0061,627.0063,675.0070,283.00
Book Value Per Share18.2915.5118.3317.0316.8014.5217.7916.6815.63
Tangible Book Value Per Share-2.09-7.17-9.58-12.81-16.52-18.373.651.20-0.62
Full-Time Employees17,00017,60018,00017,00014,40013,60011,80011,00010,000
Price to Book Ratio16.166.234.535.114.324.013.653.753.77
Return on Assets14.420.799.047.009.130.198.608.147.27
Return on Equity40.492.2825.7121.7131.700.6024.5326.0823.53
Return on Invested Capital18.771.0712.1710.3913.320.2611.9011.879.03
Quick Ratio1.401.451.271.151.131.263.013.302.67
Current Ratio1.551.601.431.291.271.403.103.382.74

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-3,862.008,510.00480.005,613.004,566.006,201.0089.005,364.005,460.00
Depreciation2,814.002,760.002,767.002,693.002,103.002,050.001,480.001,404.001,429.00
Other Funds (Non Cash)16,120.002,537.0010,305.002,965.005,718.002,760.008,451.005,272.002,161.00
Funds from Operations14,744.0013,967.0011,708.0010,309.0010,835.0010,895.009,806.009,942.009,339.00
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-265.00-3,948.00-880.00-2,303.00-1,763.00489.00-1,638.00-798.00-939.00
Income Taxes Payable212.00-2,108.00-732.00-1,768.00-568.00-364.00-778.00272.00-1,459.00
Cash from Operating Activities14,479.0010,019.0010,828.008,006.009,072.0011,384.008,168.009,144.008,400.00
Capital Expenditures-699.00-563.00-523.00-585.00-728.00-579.00-650.00-825.00-924.00
Net Assets From Acquisitions-11,946.00-1,070.00-4,840.00-1,152.00-1,797.00-1,402.00-25,742.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.00-
Purchase or Sale of Investments1,961.00-3,163.001,856.00-528.0060.00-987.0011,948.00-2,307.0015,279.00
Purchase of Investments-1,983.00-4,072.00-736.00-2,372.00-1,942.00-3,897.00-20,770.00-32,228.00-10,579.00
Sale Or Maturity of Investments3,944.00909.002,592.001,844.002,002.002,910.0032,718.0029,921.0025,858.00
Other Uses9.000.000.000.00-1.00-163.00-171.00-4,685.000.00
Other Sources20.003.0058.000.000.000.000.000.000.00
Cash from Investing Activities-10,656.00-4,793.00-3,449.00-2,265.00-2,466.00-3,131.00-14,615.00-7,817.0014,355.00
Cash Dividends Paid-4,102.00-4,003.00-3,918.00-3,809.00-3,709.00-3,605.00-3,449.00-3,222.00-2,971.00
Change in Capital Stock-1,080.00-1,514.00-728.00-768.00-1,087.00-377.00-1,327.00-1,540.00-2,611.00
Repurchase of Common Pref Stock-1,374.00-1,922.00-1,150.00-1,000.00-1,396.00-546.00-1,583.00-1,749.00-2,900.00
Sale of Common Pref Stock294.00408.00422.00232.00309.00169.00256.00209.00289.00
Proceedsfrom Stock Options294.00408.00422.00232.00309.00169.00256.00209.00289.00
Issuance or Reduction of Debt, Net1,275.00-1,788.001,494.00-270.00-1,500.00-4,750.005,684.00-2,750.00-6,250.00
Change in Long Term Debt1,275.00-1,788.001,494.00-270.00-1,500.00-4,750.005,684.00-2,750.00-6,250.00
Issuance of Long Term Debt4,085.000.003,464.001,980.000.000.008,184.000.000.00
Reduction of Long Term Debt-2,810.00-1,788.00-1,970.00-2,250.00-1,500.00-4,750.00-2,500.00-2,750.00-6,250.00
Net Financing Active Other Cash Flow-779.00-440.00-281.00-278.00-173.00-145.00-138.00-122.00-486.00
Other Financing Activities Uses-779.00-440.00-281.00-278.00-173.00-145.00-138.00-122.00-486.00
Cash from Financing Activities-4,686.00-7,745.00-3,433.00-5,125.00-6,469.00-8,877.00770.00-7,634.00-12,318.00
Exchange Rate Effect-29.0092.00-40.0057.00-63.00-35.0043.00-2.00-85.00
Net Change in Cash-892.00-2,427.003,906.00673.0074.00-659.00-5,634.00-6,309.0010,352.00
Free Cash Flow13,780.009,456.0010,305.007,421.008,344.0010,805.007,518.008,319.007,476.00
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow19.2728.2518.1528.2123.3712.7318.0816.2818.16
Deferred Taxes & Investment Tax Credit-160.00-1,844.00-962.00-1,552.00-116.00-214.00-2,098.00289.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments7,952.004,882.009,817.009,613.009,175.006,523.00
Short Term Receivables5,007.005,055.004,741.004,913.005,095.004,781.00
Inventories1,896.001,953.001,914.001,774.001,785.001,825.00
Other Current Assets1,699.002,056.002,168.002,042.001,819.001,589.00
Total Current Assets16,554.0013,946.0018,640.0018,342.0017,874.0014,718.00
Net Property, Plant & Equipment5,945.005,833.005,638.006,138.005,500.005,459.00
Total Investments and Advances739.00732.001,677.003,369.002,780.005,810.00
Intangible Assets21,737.0022,345.0024,696.0025,292.0026,284.0026,880.00
Deferred Tax Assets2,270.002,487.001,767.001,964.001,998.002,721.00
Other Assets4,163.004,019.003,860.003,918.004,098.00134.00
Total Assets51,408.0049,362.0056,278.0059,023.0058,533.0055,721.00
Short Term Debt Incl. Current Port. of LT Debt2,416.002,414.001,313.002,909.002,806.002,806.00
Accounts Payable934.00674.00645.00715.00808.00582.00
Income Tax Payable---92.00--
Other Current Liabilities8,652.007,932.007,518.008,097.008,684.007,801.00
Total Current Liabilities12,002.0011,020.009,476.0011,813.0012,298.0011,189.00
Long Term Debt23,815.0023,832.0020,861.0022,632.0022,135.0022,140.00
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities318.00333.00392.00402.00597.00652.00
Other Liabilities2,317.002,433.002,118.001,557.002,048.002,149.00
Total Liabilities38,452.0037,618.0032,847.0036,404.0037,078.0036,130.00
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity13,038.0011,829.0023,515.0022,703.0021,540.0019,674.00
Total Shareholders Equity13,038.0011,829.0023,515.0022,703.0021,540.0019,674.00
Accumulated Minority Interest-84.00-84.00-84.00-84.00-84.00-84.00
Total Equity12,954.0011,745.0023,431.0022,619.0021,456.0019,590.00
Total Liabilities & Stockholders Equity51,406.0049,363.0056,278.0059,023.0058,534.0055,720.00
Book Value Per Share10.519.5318.9318.2917.3415.84
Tangible Book Value Per Share-7.01-8.47-0.95-2.09-3.82-5.80
Full-Time Employees---17,000--
Price to Book Ratio16.166.677.627.087.017.20
Return on Assets-7.03-6.1716.3514.4214.3511.55
Return on Equity-22.34-20.5743.1940.4940.5333.26
Return on Invested Capital6.59-29.434.554.826.994.69
Quick Ratio1.221.091.771.401.311.15
Current Ratio1.381.271.971.551.451.32

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income2,430.00-10,496.002,021.002,183.003,052.001,960.00
Depreciation740.00698.00689.00687.00686.00691.00
Other Funds (Non Cash)649.0013,922.00366.001,183.008.00368.00
Funds from Operations4,021.003,537.003,255.003,931.004,405.002,841.00
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital1,014.0036.00-711.00-604.00-297.00-2,014.00
Income Taxes Payable204.00171.00-29.00-134.00-122.00-1,300.00
Cash from Operating Activities5,035.003,573.002,544.003,327.004,108.00827.00
Capital Expenditures-237.00-140.00-117.00-205.00-147.00-107.00
Net Assets From Acquisitions-19.00-11,209.00-109.00-609.00-167.00-21.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments-1.00983.002,012.00-1,033.00-116.00-1,998.00
Purchase of Investments-1.00-42.00-544.00-1,396.00-352.00-2,308.00
Sale Or Maturity of Investments0.001,025.002,556.00363.00236.00310.00
Other Uses0.0017.00-17.009.003.0010.00
Other Sources14.003.000.003.000.000.00
Cash from Investing Activities-244.00-10,347.001,770.00-1,835.00-427.00-2,116.00
Cash Dividends Paid-1,039.00-1,029.00-1,040.00-994.00-1,005.00-994.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-283.00-346.00-253.00-198.00-338.00-500.00
Repurchase of Common Pref Stock-370.00-355.00-419.00-230.00-435.00-527.00
Sale of Common Pref Stock87.009.00166.0032.0097.0027.00
Proceedsfrom Stock Options87.009.00166.0032.0097.0027.00
Issuance or Reduction of Debt, Net-19.004,068.00-2,766.00-8.00-9.00-9.00
Change in Long Term Debt-19.004,068.00-2,766.00-8.00-9.00-9.00
Issuance of Long Term Debt0.004,085.000.000.000.000.00
Reduction of Long Term Debt-19.00-17.00-2,766.00-8.00-9.00-9.00
Net Financing Active Other Cash Flow-187.00-350.00-179.00-63.00-137.00-64.00
Other Financing Activities Uses-187.00-350.00-179.00-63.00-137.00-64.00
Cash from Financing Activities-1,528.002,344.00-4,239.00-1,263.00-1,489.00-1,567.00
Exchange Rate Effect-4.00-19.00-11.005.00-5.0073.00
Net Change in Cash3,259.00-4,449.0064.00234.002,187.00-2,783.00
Free Cash Flow4,798.003,433.002,427.003,122.003,961.00720.00
Price to Free Cash Flow19.2717.6928.2028.2026.8725.72

Revenue breakdown

Biological Products, (No Diagnostic Substances)2024: 28.75B 2025: 29.44B
Europe2024: 4.63B 2025: 5.06B
Rest Of World2024: 3.53B 2025: 3.50B
United States2024: 20.59B 2025: 20.88B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-301.72%21.3M1238.3M6.12M
2026-10-151.64%20.3M1237.9M6.05M
2026-09-301.76%21.8M1237.9M6.30M
2026-09-151.48%18.3M1237.9M6.79M
2026-08-311.86%23.0M1237.9M7.43M
2026-08-141.87%23.2M1237.9M7.66M
2026-07-311.97%24.4M1238.3M7.55M
2026-07-152.04%25.3M1239.9M7.45M
2026-06-302.06%25.5M1239.9M7.12M
2026-06-151.93%23.9M1238.1M6.63M
2026-05-292.07%25.7M1239.9M6.12M
2026-05-151.87%23.1M1239.8M6.18M
2026-04-301.86%23.1M1239.7M6.49M
2026-04-151.84%22.8M1239.4M7.09M
2026-03-311.74%21.5M1239.8M7.31M
2026-03-131.61%20.0M1240.0M7.27M
2026-02-271.49%18.5M1240.0M7.32M
2026-02-131.77%21.9M1240.0M7.41M
2026-01-301.91%23.7M1237.8M7.28M
2026-01-151.86%23.0M1238.1M6.89M

Option chain

expiry 2026-11-13
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call80.0087.8591.700.007.3940.000.000.995-0.2230.002
call85.0082.8086.700.006.8800.000.000.994-0.2220.002
call90.0077.8581.700.006.3950.000.000.994-0.2200.002
call95.0073.0576.700.005.9360.000.000.993-0.2180.002
call10067.8571.750.005.4990.000.000.993-0.2160.002
call10562.8566.750.005.0820.000.000.992-0.2140.003
call11057.8561.750.004.6830.000.000.991-0.2110.003
call11552.8556.750.004.3270.000.000.990-0.2090.003
call12048.3551.750.003.9540.000.000.989-0.2060.003
call12542.8546.750.003.5920.000.000.988-0.2020.004
call12839.8543.750.003.3800.000.000.987-0.2000.004
call12939.6541.8040.712.7660.001.000.987-0.1990.004
call13038.6040.6539.622.6730.009.000.987-0.1980.004
call13137.5539.7538.702.6740.0011.000.986-0.1970.004
call13236.8038.6537.732.6710.006.000.986-0.1960.004
call13335.7037.7536.812.7700.003.000.986-0.1960.004
call13434.7536.8535.592.4900.001.000.985-0.1950.004
call13533.9535.4034.672.2465.005.000.985-0.1940.005
call13632.4534.6033.472.7183.005.000.985-0.1930.005
call13731.5033.6032.552.7173.003.000.984-0.1920.005
call13830.5532.6532.072.6722.002.000.984-0.1910.005
call13929.7032.759.722.6253.000.000.983-0.1890.005
call14027.8531.759.122.5583.000.000.983-0.1880.005
call14127.5530.7532.042.47140.000.000.982-0.1870.005
call14225.8529.757.462.4241.000.000.982-0.1860.005
call14325.7028.806.922.3571.000.000.981-0.1850.006
call14423.8527.7512.152.2914.000.000.981-0.1830.006
call14522.8526.7523.442.22410.000.000.980-0.1820.006
call14622.4025.3521.851.9855.000.000.979-0.1810.006
call14720.8524.754.912.0912.000.000.978-0.1790.006
call14820.4023.754.482.0241.000.000.978-0.1780.006
call14918.8522.758.541.9577.000.000.977-0.1760.007
call15017.8521.8018.531.89116.000.000.976-0.1740.007
call152.515.9019.3020.401.72414.000.000.973-0.1700.007
call15513.5516.1513.751.34546.000.000.961-0.2090.010
call157.510.4014.3012.601.39933.003.000.937-0.2940.015
call1607.9011.859.721.22435.000.000.906-0.3600.020
call162.56.208.807.400.90042.000.000.864-0.4170.026
call1653.956.555.500.7831771.000.701-0.9190.042
call167.51.884.503.780.68369.001.000.612-0.9180.046
call1700.313.001.600.65112546.000.497-0.8960.048
call172.50.051.850.900.62613320.000.367-0.7770.045
call1750.200.350.300.39910740.000.205-0.4780.034
call177.50.000.210.100.4546149.000.132-0.3910.026
call1800.002.150.050.5581161.000.114-0.4280.023
call182.50.001.750.130.65618.000.000.086-0.3790.019
call1850.002.130.120.75016.000.000.064-0.3240.015
call187.50.000.250.050.8412.001.000.051-0.2880.013
call1900.002.130.010.9299.001.000.047-0.2970.012
call192.50.002.130.001.0140.000.000.043-0.3060.011
call1950.002.130.001.0960.000.000.040-0.3130.010
call197.50.002.130.001.1770.000.000.038-0.3200.010
call2000.002.130.001.2550.000.000.036-0.3260.010
call2050.002.130.001.4070.000.000.033-0.3380.009
call2100.002.130.001.5520.000.000.030-0.3480.008
put80.000.002.130.004.4310.000.00-0.005-0.2230.002
put85.000.002.130.004.1000.000.00-0.006-0.2210.002
put90.000.002.130.103.78864.000.00-0.006-0.2190.002
put95.000.002.130.003.4920.000.00-0.007-0.2170.002
put1000.002.130.113.2101.000.00-0.007-0.2140.002
put1050.002.130.002.9400.000.00-0.008-0.2110.003
put1100.002.130.002.6830.000.00-0.009-0.2080.003
put1150.002.130.192.4359.000.00-0.010-0.2050.003
put1200.002.130.472.1961.000.00-0.011-0.2010.003
put1250.002.130.201.9668.000.00-0.012-0.1970.004
put1280.002.130.001.8310.000.00-0.013-0.1950.004
put1290.002.130.001.7860.000.00-0.013-0.1940.004
put1300.002.130.841.7423.000.00-0.013-0.1930.004
put1310.002.120.001.6981.000.00-0.013-0.1920.004
put1320.002.120.001.65429.000.00-0.014-0.1910.004
put1330.001.610.001.61146.000.00-0.014-0.1900.004
put1340.002.120.351.56736.000.00-0.014-0.1890.004
put1350.002.121.241.52493.000.00-0.015-0.1880.005
put1360.002.000.481.4811.000.00-0.015-0.1870.005
put1370.002.130.411.4395.000.00-0.016-0.1850.005
put1380.002.131.201.3963.000.00-0.016-0.1840.005
put1390.002.130.531.3543.000.00-0.017-0.1830.005
put1400.002.131.051.31227.000.00-0.017-0.1820.005
put1410.002.120.681.2691.000.00-0.018-0.1800.005
put1420.002.130.011.2285.000.00-0.018-0.1790.005
put1430.002.120.091.1863.000.00-0.019-0.1780.006
put1440.002.130.011.14597.001.00-0.019-0.1760.006
put1450.002.130.051.10336.000.00-0.020-0.1750.006
put1460.002.130.081.06218.000.00-0.021-0.1730.006
put1470.002.130.171.0216.000.00-0.021-0.1720.006
put1480.002.135.450.9805.000.00-0.022-0.1700.006
put1490.002.130.250.9398.000.00-0.023-0.1680.007
put1500.002.130.400.89825.000.00-0.024-0.1670.007
put152.50.002.130.230.7951260.00-0.027-0.1620.007
put1550.000.980.030.6811000.00-0.036-0.1800.010
put157.50.002.150.150.5901870.00-0.063-0.2850.015
put1600.000.170.280.48662.000.00-0.093-0.3510.020
put162.50.000.190.220.43913032.00-0.131-0.3890.026
put1650.141.930.370.81335747.00-0.299-0.9100.042
put167.50.672.610.800.76030017.00-0.388-0.9090.046
put1701.643.552.100.71319.009.00-0.503-0.8860.048
put172.52.474.603.420.62681.001.00-0.633-0.7660.045
put1754.306.756.400.7226.000.00-0.795-0.4680.034
put177.56.809.056.330.8256.000.00-0.868-0.3800.026
put1808.3512.208.801.1451.000.00-0.886-0.4170.023
put182.510.8014.700.001.2880.000.00-0.914-0.3680.019
put18513.7017.200.001.4220.000.00-0.936-0.3130.015
put187.515.7519.700.001.5510.000.00-0.949-0.2760.013
put19018.3022.200.001.6750.000.00-0.953-0.2850.012
put192.520.8024.700.001.7940.000.00-0.957-0.2930.011
put19524.1027.2025.721.9090.000.00-0.959-0.3010.010
put197.525.8029.700.002.0210.000.00-0.962-0.3070.010
put20028.3032.200.002.1290.000.00-0.964-0.3130.010
put20533.8537.200.002.3360.000.00-0.967-0.3240.009
put21038.3042.200.002.5340.000.00-0.970-0.3340.008

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-094Statement of changes in beneficial ownership of securities2026-11-06SEC
2026-11-06144Filing for proposed sale of securities under Rule 144.SEC
2026-11-064Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-11-06SCHEDULE 13GSEC
2026-11-0613F-HRFurther understand that each of 13F-HR, 13F-NT, and amendments thereto are mandatory electronic filings (hardship exemption exists to submit in paper; never used to the knowledge of IM staff);2026-09-30SEC
2026-11-04144Filing for proposed sale of securities under Rule 144.SEC
2026-11-024Statement of changes in beneficial ownership of securities2026-10-30SEC
2026-10-30144Filing for proposed sale of securities under Rule 144.SEC
2026-10-3010-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-298-KCurrent report2026-10-29SEC
2026-10-164Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-10-164Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-10-15144Filing for proposed sale of securities under Rule 144.SEC
2026-10-15144Filing for proposed sale of securities under Rule 144.SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-09-234Statement of changes in beneficial ownership of securities2026-09-22SEC
2026-09-164Statement of changes in beneficial ownership of securities2026-09-15SEC
2026-09-164Statement of changes in beneficial ownership of securities2026-09-15SEC
2026-09-15144Filing for proposed sale of securities under Rule 144.SEC
2026-09-15144Filing for proposed sale of securities under Rule 144.SEC
2026-09-114Statement of changes in beneficial ownership of securities2026-09-10SEC
2026-09-114Statement of changes in beneficial ownership of securities2026-09-10SEC
2026-09-114Statement of changes in beneficial ownership of securities2026-09-10SEC
2026-09-114Statement of changes in beneficial ownership of securities2026-09-10SEC
2026-09-114Statement of changes in beneficial ownership of securities2026-09-10SEC
2026-09-024Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-08-274Statement of changes in beneficial ownership of securities2026-08-26SEC
2026-08-26144Filing for proposed sale of securities under Rule 144.SEC
2026-08-26N-PXAnnual Report of Proxy Voting Record of Registered Management Investment Companies filed on Form N-PX2026-06-30SEC
2026-08-214Statement of changes in beneficial ownership of securities2026-08-20SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110022.80M4
2026-10005.94M4
2026-09003.10M3
2026-08009.62M5
2026-07002.67M3
2026-06002.72M3
2026-05004.07M2
2026-04002.14M3
2026-03002.23M3
2026-020023.58M4
2026-010018.37M5
2025-12001.98M3
2025-110013.03M7

Institutional holders

Manager% owned
BlackRock, Inc.9.81%
VANGUARD CAPITAL MANAGEMENT LLC6.53%
STATE STREET CORP4.93%
FMR LLC4.70%
Capital World Investors3.30%
Invesco Ltd.3.21%
VANGUARD PORTFOLIO MANAGEMENT LLC2.84%
GEODE CAPITAL MANAGEMENT, LLC2.43%
PRICE T ROWE ASSOCIATES INC /MD/2.42%
MORGAN STANLEY1.93%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND3.17%
VANGUARD 500 INDEX FUND2.59%
Guggenheim Total Return Bond Fund2.21%
T. Rowe Price New Income Fund, Inc.2.16%
Invesco QQQ Trust, Series 12.12%
iShares Ultra Short Duration Bond Active ETF1.66%
VANGUARD INTERMEDIATE-TERM CORPORATE BOND INDEX FUND1.66%
Core Fixed Income Fund1.53%
iShares iBoxx $ Investment Grade Corporate Bond ETF1.49%
VANGUARD INTERMEDIATE-TERM INVESTMENT-GRADE FUND1.43%

OakChart. GILD. Cached 15 minutes.